State Street Corp Mirum Pharmaceuticals, Inc. Put Options Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MIRM
# of Institutions
184Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$219 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$147 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$111 Million1.34% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$93.2 Million0.04% of portfolio
-
Black Rock Inc. New York, NY2.45MShares$82.6 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.24B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...